HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Investment analysts at Northland Securities lifted their Q3 2027 earnings per share (EPS) estimates for shares of HIVE Blockchain Technologies in a note issued to investors on Tuesday, November 10th. Northland Securities analyst M. Grondahl now expects that the company will post earnings of ($0.18) per share for the quarter, up from their previous forecast of ($0.19). Northland Securities also issued estimates for HIVE Blockchain Technologies’ Q4 2027 earnings at ($0.13) EPS.
Separately, Chardan Capital raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Monday, July 27th. Two analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy”.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a technology company in the Application Software industry.
Featured Articles
- Five stocks we like better than HIVE Blockchain Technologies
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
